Search details
1.
OpenSAFELY: A platform for analysing electronic health records designed for reproducible research.
Pharmacoepidemiol Drug Saf
; 33(6): e5815, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38783412
2.
Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021.
PLoS Comput Biol
; 18(11): e1010724, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36417468
3.
Response to COVID-19 in South Korea and implications for lifting stringent interventions.
BMC Med
; 18(1): 321, 2020 10 09.
Article
in English
| MEDLINE | ID: mdl-33032601
4.
An SIS model for cultural trait transmission with conformity bias.
Theor Popul Biol
; 90: 56-63, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24071632
5.
The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021.
Microb Genom
; 9(2)2023 02.
Article
in English
| MEDLINE | ID: mdl-36745545
6.
Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number.
Epidemics
; 40: 100604, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35780515
7.
Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study.
EClinicalMedicine
; 48: 101419, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35572721
8.
Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys.
Lancet Reg Health Eur
; 21: 100462, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35915784
9.
Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
Science
; 375(6587): 1406-1411, 2022 03 25.
Article
in English
| MEDLINE | ID: mdl-35133177
10.
Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England.
Nat Commun
; 13(1): 4500, 2022 08 03.
Article
in English
| MEDLINE | ID: mdl-35922409
11.
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.
Lancet Respir Med
; 10(4): 355-366, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35085490
12.
Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility.
Sci Rep
; 11(1): 13903, 2021 07 06.
Article
in English
| MEDLINE | ID: mdl-34230530
13.
Resurgence of SARS-CoV-2: Detection by community viral surveillance.
Science
; 372(6545): 990-995, 2021 05 28.
Article
in English
| MEDLINE | ID: mdl-33893241
14.
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
Science
; 374(6574): eabl9551, 2021 Dec 17.
Article
in English
| MEDLINE | ID: mdl-34726481
15.
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England.
Sci Transl Med
; 13(602)2021 07 14.
Article
in English
| MEDLINE | ID: mdl-34158411
16.
Reduction in mobility and COVID-19 transmission.
Nat Commun
; 12(1): 1090, 2021 02 17.
Article
in English
| MEDLINE | ID: mdl-33597546
17.
Anonymised and aggregated crowd level mobility data from mobile phones suggests that initial compliance with COVID-19 social distancing interventions was high and geographically consistent across the UK.
Wellcome Open Res
; 5: 170, 2020.
Article
in English
| MEDLINE | ID: mdl-32954015
18.
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment.
Wellcome Open Res
; 5: 81, 2020.
Article
in English
| MEDLINE | ID: mdl-32500100
19.
State-level tracking of COVID-19 in the United States.
Nat Commun
; 11(1): 6189, 2020 12 03.
Article
in English
| MEDLINE | ID: mdl-33273462
20.
The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries.
Science
; 369(6502): 413-422, 2020 07 24.
Article
in English
| MEDLINE | ID: mdl-32532802